Speakers

Gonçalo Abecasis, Ph.D.
VP & Chief Genomics and Data Science Officer
Regeneron
Amy Abernethy, M.D., Ph.D.
Former Principal Deputy Commissioner
FDA
Daniel Burkhardt, Ph.D.
Manager of Strategic Scientific Projects
Cellarity
Zandy Forbes, Ph.D.
President & CEO
MeiraGTx
Chris Garabedian
CEO
Xontogeny
Andrei Georgescu, Ph.D.
Co-founder & CEO
Vivodyne
David Goldstein, Ph.D.
Co-founder & CEO
Actio Biosciences
Jane Grogan, Ph.D.
EVP, Head of Research
Biogen
Anika Gupta, Ph.D.
Principal
GV
Colin Hill
CEO
Aitia
Chris Hollowood, Ph.D.
CEO
Syncona
Olivier Leclerc
Senior Partner
McKinsey & Company
John Lepore, M.D.
CEO
ProFound Therapeutics
Patrick Lyden, M.D.
Professor
Keck School of Medicine of USC
Mathai Mammen, M.D., Ph.D.
Chairman & CEO
FogPharma
Fiona Marshall, Ph.D.
President of Biomedical Research
Novartis
Clare Murray, Ph.D.
SVP Corporate Development & Operations
Life Edit Therapeutics
Rajesh Parekh, Ph.D.
Senior Partner
McKinsey & Company
Elizabeth Anne Stringer, Ph.D.
Chief Scientific Officer
Nashville Biosciences
Paul Peter Tak, M.D., Ph.D.
President & CEO
Candel Therapeutics
Gregory Verdine, Ph.D.
Co-Founder, President & CEO
LifeMine Therapeutics
Carolyne Zimmermann
Chief Business Officer
SonoThera